
Wittycell is developing novel adjuvant products for therapeutic and prophylactic Vaccines based on the Company’s proprietary technology.
Since its foundation in 2005, Wittycell S.A.S. has developed a new family of vaccine adjuvants , which aim to...
Les adjuvants développés par Wittycell sont la mise en pratique de la science récompensée par le......
